Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top ...

A potential Sycamore buyout sounded like good news--until analysts revealed the brutal reality behind the deal.

From Walgreens' breakup to Forever 21's pending bankruptcy, M&A and drama unfold in this week's edition of Deal Dispatch.

Walgreens shares fell more than 5% Friday as details about a potential sale emerged and one analyst team said the stock had ...

S&P 500 rises Friday despite stagflation fears. Safe-haven stocks outperform, while Nvidia, Dell, and HP Inc. slide on ...

Wall Street’s main indexes were mixed in choppy trading on Friday as investors avoided large bets after data showed consumer ...

CNBC's David Faber breaks down the details on Sycamore's possible deal with Walgreens. Dame Maggie Smith appeared in over 50 ...

Walgreens Boots (NASDAQ:WBA) fell 4.7% after a report that a Sycamore Partners deal for the drugstore chain is unlikely to ...

The deal is not yet finalized. Other news includes: tariffs on the pharmaceutical industry and what it means for medicine; Pfizer putting emphasis on merit in the face of DEI overhaul; and more.

Explore the uncertain future of Walgreens Boots Alliance (WBA) amid buyout hurdles, litigation risks & industry challenges.

The deal hype started in early-December, when the Wall Street Journal reported Walgreens was in talks to sell itself to Sycamore Partners. Read: Walgreens' stock could see its best day ever. Is a ...